FCAM
GILD icon

F&C Asset Management’s Gilead Sciences GILD Stock Holding History

F&C Asset Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		$25.6M Sell
361,693
-1,112
-0.3% -$87.2K 0.32% 74
2013
Q4 		$27.3M Sell
362,805
-237,088
-40% -$16.5M 0.33% 69
2013
Q3 		$37.7M Buy
599,893
+7,144
+1% +$427K 0.49% 37
2013
Q2 		$30.4M Buy
+592,749
New +$30.9M 0.42% 47

Other funds holding GILD

BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

F&C Asset Management's GILD Position: Q1 2014 in Review

F&C Asset Management reduced its Gilead Sciences (GILD) stake by 0.31% in Q1 2014, selling an estimated $87.2K and leaving 361,693 shares worth $25.6M. The position accounts for 0.32% of the portfolio, ranked #74.

F&C Asset Management first reported a position in GILD in Q2 2013 and has held it in 4 quarters since. The position peaked at $37.7M in Q3 2013. 1,188 funds tracked by Wall St. Rank hold GILD as of Q1 2014.

  • F&C Asset Management held 361,693 shares of Gilead Sciences worth $25.6M as of Q1 2014.
  • F&C Asset Management sold 1,112 Gilead Sciences shares in Q1 2014, an estimated $87.2K.
  • Gilead Sciences made up 0.32% of F&C Asset Management's portfolio in Q1 2014, its #74 holding.
  • F&C Asset Management first reported a position in Gilead Sciences in Q2 2013 and has held it in 4 quarters since.
  • F&C Asset Management's Gilead Sciences position peaked at $37.7M in Q3 2013.
  • 1,188 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2014.

Based on F&C Asset Management's 13F filing for Q1 2014, filed 14 May 2014.